PATH EX, Inc.

Hemotune

This company develops a magnetic blood purification platform using nanoengineered beads to remove specific disease-causing substances for patients with sepsis or requiring gene therapy.

Advanced Perfusion Diagnostics

This company develops single-use devices for non-invasive, continuous microcirculation assessment and early sepsis detection for clinicians in critical care and surgical settings.

SepsiScan

This company develops bedside imaging devices for real-time microcirculation monitoring and early sepsis diagnosis for intensive care units and hospitals.

Noninvasix

This company develops non-invasive optoacoustic monitoring technology to measure central venous oxygenation levels for clinicians treating patients with sepsis and septic shock.

CytoVale

This medical diagnostics company develops the IntelliSep test to provide rapid sepsis detection for hospital emergency departments and health systems.

FAST Biomedical

This company develops medical technology for measuring blood volume and kidney function to assist healthcare professionals treating heart failure and sepsis patients.

Deepull

Deepull develops automated diagnostic systems that identify pathogens and antibiotic resistance directly from blood samples for healthcare providers treating sepsis and acute infections.

Inotrem

This biopharmaceutical company develops immunotherapies targeting the TREM-1 pathway for patients suffering from acute inflammatory syndromes such as septic shock.